Readers hoping to buy Pfizer Inc. ( NYSE:PFE ) for its dividend will need to make their move shortly, as the stock is...
Competition is heating up in the GLP-1 space as Amgen gets closer to the finish line with its candidate.
Pfizer had a surprise beat in its COVID portfolio despite dim forecasts, but the company is still not feeling the love in its stock.